Product Code: GVR-3-68038-889-3
Topical Wound Agents Market Growth & Trends:
The global topical wound agents market size is estimated to reach USD 2.84 billion by 2030, registering to grow at a CAGR of 7.74% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rising prevalence of chronic injuries, growing number of surgical procedures, launch of technologically advanced products, and increasing cases of burns globally are the key driving factors for the market.
Topical wound agents generally provide adequate moisture to the bruise and allow autolytic debridement. The increasing prevalence of chronic injuries and rising number of surgical procedures are the key driving factors for market growth. For instance, as per a report published by the ScienceDirect in 2018, surgical infection has highest prevalence rate of around 4.0%, followed by diabetic foot ulcers which are around 3.4%. In addition, rising number of medical facilities for treating unhealed bruises across the globe is also expected to surge market growth over the forecast period. In May 2019, Dalvkot Wound Care (DWC) established the first medical facility for treating bruises in Bangalore, India, which aims to provide remedies to chronic injuries. Thus, such developments may boost the demand for topical wound agents, as they are specifically used for such conditions. Furthermore, new product launches by key players may also positively impact market growth. For instance, Arch Therapeutics, Inc., launched AC5 Topical Gel, which got its FDA approval in October 2019. This gel allows rapid injury healing with minimal risk of getting further complications. Therefore, such factors are anticipated to propel growth of the market over the forecast period.
Topical Wound Agents Market Report Highlights:
- The creams segment held the largest market share, 42.15%, in 2024 and is expected to grow fastest during the forecast period.
- The acute wounds segment held the largest share in 2024. This segment includes surgical & traumatic wounds and burns.
- The hospitals segment held the largest share of 46.34% in 2024 and it is anticipated to witness the fastest growth in the coming years.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Topical Wound Agents Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising prevalence of chronic wounds
- 3.2.1.2. Increasing number of surgeries and trauma cases
- 3.2.1.3. Advancements in topical wound agents
- 3.2.2. Market restraint analysis
- 3.2.2.1. Recalls of topical wound agents
- 3.2.3. Market opportunity analysis
- 3.2.3.1. Expansion opportunities in emerging economies
- 3.2.3.2. Clinical trials focusing on topical wound agents
- 3.2.4. Market challenge analysis
- 3.2.4.1. Complications and adverse events associated with the use of topical wound agents
- 3.3. Topical Wound Agents Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal Landscape
- 3.3.2.2. Economic and Social Landscape
- 3.3.2.3. Technological landscape
Chapter 4. Topical Wound Agents Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Topical Wound Agents Market Movement Analysis
- 4.3. Global Topical Wound Agents Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Creams
- 4.4.1. Creams market estimates and forecast 2018 to 2030 (USD Million)
- 4.5. Gels
- 4.5.1. Gels market estimates and forecast 2018 to 2030 (USD Million)
- 4.6. Sprays
- 4.6.1. Sprays market estimates and forecast 2018 to 2030 (USD Million)
- 4.7. Others
- 4.7.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Topical Wound Agents Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Topical Wound Agents Market Movement Analysis
- 5.3. Global Topical Wound Agents Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Chronic Wounds
- 5.4.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.2. Diabetic foot ulcers
- 5.4.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.3. Pressure ulcers
- 5.4.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.4. Venous leg ulcers
- 5.4.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.4.5. Others
- 5.4.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)
- 5.5. Acute Wounds
- 5.5.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Surgical & traumatic wounds
- 5.5.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.3. Burns
- 5.5.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Topical Wound Agents Devices: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Topical Wound Agents Market Movement Analysis
- 6.3. Global Topical Wound Agents Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 6.4. Hospitals
- 6.4.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 6.5. Clinics
- 6.5.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Topical Wound Agents Market: Regional Estimates & Trend Analysis
- 7.1. Regional Dashboard
- 7.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
- 7.3. North America
- 7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Competitive scenario
- 7.3.2.3. Regulatory framework
- 7.3.2.4. Reimbursement scenario
- 7.3.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Competitive scenario
- 7.3.3.3. Regulatory framework
- 7.3.3.4. Reimbursement scenario
- 7.3.3.5. Canada market estimates and forecasts, 2018 - 2030
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Competitive scenario
- 7.3.4.3. Regulatory framework
- 7.3.4.4. Reimbursement scenario
- 7.3.4.5. Mexico market estimates and forecasts, 2018 - 2030
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Competitive scenario
- 7.4.1.3. Regulatory framework
- 7.4.1.4. Reimbursement scenario
- 7.4.1.5. UK market estimates and forecasts, 2018 - 2030
- 7.4.2. Germany
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. Reimbursement scenario
- 7.4.2.5. Germany market estimates and forecasts, 2018 - 2030
- 7.4.3. France
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Reimbursement scenario
- 7.4.3.5. France market estimates and forecasts, 2018 - 2030
- 7.4.4. Italy
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Regulatory framework
- 7.4.4.4. Reimbursement scenario
- 7.4.4.5. Italy market estimates and forecasts, 2018 - 2030
- 7.4.5. Spain
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Competitive scenario
- 7.4.5.3. Regulatory framework
- 7.4.5.4. Reimbursement scenario
- 7.4.5.5. Spain market estimates and forecasts, 2018 - 2030
- 7.4.6. Denmark
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Competitive scenario
- 7.4.6.3. Regulatory framework
- 7.4.6.4. Reimbursement scenario
- 7.4.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 7.4.7. Sweden
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Competitive scenario
- 7.4.7.3. Regulatory framework
- 7.4.7.4. Reimbursement scenario
- 7.4.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 7.4.8. Norway
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Competitive scenario
- 7.4.8.3. Regulatory framework
- 7.4.8.4. Reimbursement scenario
- 7.4.8.5. Norway market estimates and forecasts, 2018 - 2030
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Competitive scenario
- 7.5.1.3. Regulatory framework
- 7.5.1.4. Reimbursement scenario
- 7.5.1.5. Japan market estimates and forecasts, 2018 - 2030
- 7.5.2. India
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. Reimbursement scenario
- 7.5.2.5. India market estimates and forecasts, 2018 - 2030
- 7.5.3. China
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Reimbursement scenario
- 7.5.3.5. China market estimates and forecasts, 2018 - 2030
- 7.5.4. South Korea
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. Reimbursement scenario
- 7.5.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 7.5.5. Australia
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Competitive scenario
- 7.5.5.3. Regulatory framework
- 7.5.5.4. Reimbursement scenario
- 7.5.5.5. Australia market estimates and forecasts, 2018 - 2030
- 7.5.6. Thailand
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Competitive scenario
- 7.5.6.3. Regulatory framework
- 7.5.6.4. Reimbursement scenario
- 7.5.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Competitive scenario
- 7.6.1.3. Regulatory framework
- 7.6.1.4. Reimbursement scenario
- 7.6.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 7.6.2. Argentina
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Reimbursement scenario
- 7.6.2.5. Argentina market estimates and forecasts, 2018 - 2030
- 7.7. MEA
- 7.7.1. South Africa
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Competitive scenario
- 7.7.1.3. Regulatory framework
- 7.7.1.4. Reimbursement scenario
- 7.7.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 7.7.2. Saudi Arabia
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Reimbursement scenario
- 7.7.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 7.7.3. UAE
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Reimbursement scenario
- 7.7.3.5. UAE market estimates and forecasts, 2018 - 2030
- 7.7.4. Kuwait
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Competitive scenario
- 7.7.4.3. Regulatory framework
- 7.7.4.4. Reimbursement scenario
- 7.7.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 8. Competitive Landscape
- 8.1. Market Participant Categorization
- 8.2. Key Company Profiles
- 8.2.1. Smith+Nephew
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Molnlycke Health Care AB
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. Teva Pharmaceutical Industries Ltd
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. Arch Therapeutics, Inc.
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Viatris Inc
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Ipca Laboratories Ltd.
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Chiesi USA
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. SERDA Therapeutics
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.3. Heat Map Analysis/ Company Market Position Analysis
- 8.4. Estimated Company Market Share Analysis, 2024
- 8.5. List of Other Key Market Players